New oral therapy of CETP inhibition for lipid lowering - PACE-CME

New oral therapy of CETP inhibition for lipid lowering

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

How to overcome the excess ASCVD risk conferred by Lp(a)?
How to overcome the excess ASCVD risk conferred by Lp(a)?
EAS 2022
How to overcome the excess ASCVD risk conferred by Lp(a)?
- Prof. Alberico Catapano, PhD
Wake-up call to shift focus from treating CVD to preserving CV health
Wake-up call to shift focus from treating CVD to preserving CV health
EAS 2022
Wake-up call to shift focus from treating CVD to preserving CV health
- Prof. Lale Tokgözoğlu, MD
Need for a stratified approach to improve treatment of IHD
Need for a stratified approach to improve treatment of IHD
EAS 2022
Need for a stratified approach to improve treatment of IHD
- Prof. Filippo Crea, MD
Targeting the ANGPTL3 pathway for lowering TG-rich lipoproteins
Targeting the ANGPTL3 pathway for lowering TG-rich lipoproteins
EAS 2022
Targeting the ANGPTL3 pathway for lowering TG-rich lipoproteins
- Nicholas Marston, MD